-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, ALL, AML, antibodies, Biological, CRS, Follicular Lymphoma, HSCs, Leukemia, therapy sequence, viral, bone marrow, CLL, CML, Diseases, Lymphoma (any), Non-Biological, Combinations, Mantle Cell Lymphoma, Therapies, Adverse Events, chemotherapy, Genetic Disorders, MDS, Non-Hodgkin Lymphoma, Pediatric, B-Cell Lymphoma, Biological Processes, DLBCL, MPN, Cell Lineage, immunotherapy, Infectious Diseases, Plasma Cell Disorders, infusion, Lymphoid Malignancies, Study Population, Clinically relevant, Myeloid Malignancies, Quality Improvement , immune mechanism, transplantation, inflammation, stem cells
Monday, December 7, 2020: 7:00 AM-3:30 PM

Elena Vladimirovna Semenova, PhD1*, Olesia V Paina, PhD2*, Zhemal Zarifovna Rakhmanova, Dr.2*, Polina Valerievna Kozhokar, Dr.2*, Anastasia S Frolova, Dr2*, Kirill Alexandrovich Ekushov, Dr.2*, Tatiana A Bykova, MD, PhD2*, Anna A. Osipova2*, Inna Markova2*, Sergey N. Bondarenko2*, Boris I Smirnov3*, Ildar M Barkhatov, MD, PhD2*, Aleksandr Alyanski2*, Elena V. Babenko2*, Ivan S. Moiseev2*, Axel R. Zander4 and Ludmila S Zubarovskaya, MD, PhD, professor2*

1RM Gorbacheva Research Institute, Pavlov University, Saint-Petrsburg, Russia
2RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russian Federation
3Saint-Petersburg Electrotechnical University, St. Petersburg, Russian Federation
4University of Hamburg, Hamburg, Germany

Gary Simmons, DO1, Roy Sabo, PhD2*, Maja Radic, BS3*, May Aziz, Pharm.D4*, Kelly Hawks, Pharm.D4*, Robyn J Bernard, BS3*, Ali Jafri, BS3*, Catherine H Roberts, PhD5*, Ramesh Natarajan1*, Alpha Fowler1* and Amir Ahmed Toor, MD1*

1Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA
2Department of Biostatistics, Virginia Commonwealth University, Richmond, VA
3Virginia Commonwealth University, Richmond
4School of Pharmacy, Virginia Commonwealth University, Richmond
5Department of Internal Medicine, Virginia Commonwealth University Health System, Richmond, VA

Roberta Azevedo1*, Vinicius Campos Molla, MD1,2*, Jessica Fernandes Ramos, MD, PhD1,3*, Danilo Belchior Ponciano1*, Pedro Henrique Arruda De Moraes, MD1,4*, Ana Rita Da Fonseca, MD1,2*, Maria Cristina Nunez Seiwald, MD1,2*, Mariana Serpa, MD1*, Aliana Meneses Ferreira, MD1, Roberta Shcolnik Szor, MD1*, Rayana Bomfim Leonel, MD1,2*, Erick Menezes Xavier, MD1*, Luciana Tucunduva, MD1*, Vanderson Rocha, MD, PhD3,5*, Yana Novis, MD1*, Esper Kallas, MD, PhD1*, Marcio Nucci, MD, PhD6 and Celso Arrais-Rodrigues, MD, PhD1,7

1Hospital Sírio Libanês, São Paulo, Brazil
2Universidade Federal de São Paulo, São Paulo, Brazil
3Universidade de São Paulo, São Paulo, Brazil
4Department of Hematology and Hemotherapy, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil
5Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
6Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
7Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil

Apostolia Papalexandri, MD*, Eleni Gavriilaki, MD, Anna Vardi, MD, PhD*, Eirini Baldoumi*, Christos Demosthenous, MD, Natasa Konstantinou, MD*, Tasoula Touloumenidou*, Panagiota Zerva*, Fotini Kika*, Angeliki Paleta*, Michalis Iskas*, Ioannis Batsis*, Despina Mallouri*, Evangelia Yannaki, MD*, Ioanna Sakellari, MD PhD* and Achilles Anagnostopoulos

Hematology Department and HCT Unit, George Papanikolaou General Hospital, Thessaloniki, Greece

Alida Dominietto, MD1*, Stefano Vagge, MD2*, Susanta Hui, PhD3*, Carmen Di Grazia, MD4*, Teresa Lamparelli, MD1*, Stefania Bregante, MD1*, Anna Maria Raiola, MD4*, Riccardo Varaldo, MD1*, Francesca Gualandi, MD1*, Renzo Corvò, MD2* and Emanuele Angelucci, MD5

1Ematologia e Centro Trapianti, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
2Radioterapia Oncologica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
3Department of Radiation Oncology, Beckman Research Institute, City of Hope, Duarte, CA
4Ematologia e Centro Trapianti,, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
5Ematologia e Centro Trapianti, IRCCS Ospedale Policlinico San Martino, Genova, Italy

Christopher Nunes Gomes1*, Valerie Seegers, MD2*, Aline Schmidt, MD PhD3*, Corentin Orvain, MD, PhD3*, Alban Villate, MD4*, Anne Bouvier, MD PhD5*, Gille Simard, MD6*, Aurélien Sutra Del Galy, MD7*, Sylvie Francois, MD3*, Aurelien Giltat, MD3*, Jean Baptiste Robin, MD3*, Yves Delneste, PhD8*, Norbert Ifrah, MD PhD3, Mathilde Hunault, MD PhD3* and Sylvain Thepot, MD3*

1Clinical Hematology, Angers University Hospital, ANGERS, France
2Biométrie, Institut Cancérologique de l'Ouest, Angers, FRA
3Clinical Hematology, Angers University Hospital, Angers, France
4Service d'hématologie et thérapie cellulaire, Hôpital Bretonneau, CHRU de Tours, Tours, France
5Angers University Hospital, Angers, France
6Angers University Hospital, ANGERS, France
7Department of Hematology Transplantation, Saint-Louis Hospital, AP-HP, Paris, France
8Inserm U892, Angers, FRA

Asad Bashey, MD, PhD1, Xu Zhang, PhD2*, Lawrence E Morris, MD1, H. Kent Holland, MD1, Scott R. Solomon, MD3 and Melhem Solh, MD1

1Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA
2Center for Clinical and Transitional Sciences, University of Texas Health Science Center, Houston, TX
3Blood and Marrow Transplant Program, Northside Hospital, Atlanta, GA

Israel Henig, MD1*, Oryan Henig2*, Haggai Bar-Yoseph2*, Hanin Daoud2*, Dana Yehudai-Ofir, MD3*, Ilana Oren2* and Tsila Zuckerman, MD3,4

1Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, MI, Israel
2Rambam Health Care Campus, Haifa, Israel
3Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
4The Ruth and Bruce Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel

Omar Albanyan, MD1, Seongho Kim, Ph.D2*, Anupama Kottam, MD3*, Abhinav Deol, MD1, Lois Ayash, MD1, Voravit Ratanatharathorn, MD1, Joseph P. Uberti, M.D., Ph.D.1 and Dipenkumar Modi, MD1

1Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute/Wayne State University, Detroit, MI
2Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI
3Department of Cardiology, Wayne State University, Detroit, MI

Vinicius Campos Molla, MD1,2*, Roberta Azevedo2*, Jessica Fernandes Ramos, MD, PhD2,3*, Danilo Belchior Ponciano1,2*, Pedro Henrique Arruda de Moraes, MD1,2*, Ana Rita Da Fonseca, MD1,2*, Maria Cristina Nunez Seiwald, MD1,2*, Mariana Serpa, MD2*, Aliana Meneses Ferreira, MD2,3, Roberta Shcolnik Szor, MD2,3*, Rayana Bomfim Leonel, MD1,2*, Erick Menezes Xavier, MD2*, Vanderson Rocha, MD, PhD2,3,4*, Luciana Tucunduva, MD2*, Yana Novis, MD2*, Marcio Nucci, MD, PhD5, Esper Kallas, MD, PhD2,3* and Celso Arrais, MD, PhD2,6*

1Universidade Federal de São Paulo, São Paulo, Brazil
2Hospital Sírio Libanês, São Paulo, Brazil
3Universidade de São Paulo, São Paulo, Brazil
4Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
5Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
6Division of Hematology, Universidade Federal de São Paulo, São Paulo, Brazil

Shaik Rashid, MD*, Matthew Carabasi, MD*, Joanne Filicko-O'Hara, MD*, John L. Wagner, MD*, William O'Hara, PharmD*, Usama Gergis, MD, Neal Flomenberg, MD and Dolores Grosso, DNP, CRNP

Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA

Jinhua Ren1*, Tingting Xiao1*, Yingxi Weng1*, Rong Zheng1*, Yu Zhang1*, Jingjing Xu1*, Xiaofeng Luo1*, Zhihong Zheng1*, Zhizhe Chen1*, Jianda Hu, MD, PhD2 and Ting Yang, MD, PhD3

1Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
2Fujian Medical University Union Hospital, Fuzhou, China
3Department of Hematology, Fujian Medical University Union Hospital,Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fuzhou, China

Joseph Noye1,2*, Glen A Kennedy, MBBS FRACP FRCPA2,3* and Ashleigh P Scott, MBBS FRACP FRCPA2,4

1Department of Haematology and BMT, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
2School of Medicine, University of Queensland, St Lucia, QLD, Australia
3Department of Haematology, Royal Brisbane and Women's Hospital, Brisbane, Australia
4Department of Haematology and BMT, Royal Brisbane and Women's Hospital, Herston, QLD, Australia

Brandi Handel, MSN, RN1*, Nicole McEntee, BSN, RN, OCN, BMTCN1*, Anne Tyno, RN, MSN, APN-C2*, Patricia Andrews, BSN, RN, OCN1*, Patricia Lafaro, BS, RN, CIC1*, Vimal Patel, MD3*, Dale G Schaar, MD, PhD3, Roger Strair, MD, PhD4* and Dennis Cooper, MD3

1Robert Wood Johnson University Hospital, New Brunswick, NJ
2Rutgers Cancer Institute of New Jersey, New Brunswick
3Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
4Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

Lea Bosdure, Resident1*, Jean-Hugues Dalle, MD, PhD2, Catherine Paillard, MD, PhD3*, Mony Fahd, MD MSc4*, Valerie Coiteux, MD5*, Nadine Petitpain, PharmD6*, Danièle Bensoussan7*, Jacques-Olivier Bay, MD, PhD8, Marie Thérèse Rubio, MD, PhD9* and Cecile Pochon, MD10*

1CHU de Besancon, Besancon University, Besancon, France
2Robert Debre Hospital, GH APHP Nord Université de Paris, Hematology and Immunology Department, Paris, France
3Pediatric Hematology Department, Strasbourg University Hospital, Strasbourg, France
4Hematology and Immunology Department, Robert-Debré Hospital, GH APHP Nord Université de Paris, Paris, France
5Hematology Department, CHRU Lille, Lille, FRA
6CHRU Nancy, Centre Régional de Pharmacovigilance, Nancy, France
7Centre Hospitalier Universitaire De De Nancy, Vandeouvre Les Nancy, FRA
8Service d'Hematologie Clinique et de Therapie Cellulaire, CHU, Universite d'Auvergne, EA7453, CIC501, Clermont-Ferrand, France
9CHRU Nancy, Hôpital Brabois, Vandœuvre-les Nancy, France
10CHRU de Nancy - Université de Lorraine, NANCY, FRA

Daria Kobyzeva, MD1*, Larisa Shelikhova, PhD2*, Zhanna Shekhovtsova, MD3*, Rimma Khismatullina, MD4*, Maria Ilushina, MD5*, Anna Loginova5*, Alexey Nechesnuyk, PhD6* and Michael Maschan, PhD, MSc7

1«Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology», Moscow, Russian Federation
2Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation
3Dmitry Rogachev National Medical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation
4Dmitriy Rogachev National Medical Research Centre of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation
5Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation
6Department of Radiation Oncology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation
7Dmitriy Rogachev National Medical Research Centre of Pediatric Hematology, Oncology and Immunology, Moscow, Russia

Baptiste Le Calvez1*, Thierry Guillaume, MD, PhD2*, Pierre Peterlin, MD2,3*, Alice Garnier, MD4,5*, Amandine Le Bourgeois, MD6*, Marie Audrain, MD, PhD7*, Marion Eveillard2,8*, Thomas Dejoie9*, Béatrice Mahé, MD10*, Viviane Dubruille11*, Nicolas Blin, MD6*, Cyrille Touzeau12*, Thomas Gastinne, MD6*, Anne Lok13*, Benoit Tessoulin, MD, PhD6,14*, Sophie Vantyghem6*, Steven Le Gouill, MD, PhD15,16, Philippe Moreau17,18*, Marie C Bene, PharmSci, PhD2,8* and Patrice Chevalier, MD, PhD19*

1Service d'hématologie, CHU de Nantes, Nantes, France
2CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France
3Clinical Hematology, HOPITAL HOTEL DIEU ET HME, NANTES CEDEX 1, France
4Service d’Hématologie, CHU Nantes, Nantes, France., Nantes, France
5Department of Hematology, Nantes University Hospital, Nantes, France
6Clinical Hematology, Nantes University Hospital, Nantes, France
7Immunology, Nantes University Hospital, Nantes, FRA
8Hematology Biology, Nantes University Hospital, Nantes, France
9university hospital, Nantes, France
10CHU Nantes Hôtel-Dieu, Nantes, France
11CHU De Nantes, Nantes, FRA
12Hematology Clinic, University Hospital Hôtel-Dieu, Nantes, France
13Clinical Hematology, Nantes University Hospital, Nantes, FRA
14CRCINA, INSERM 1232, CNRS, Université d'Angers, Université de Nantes, Nantes, France
15CRCINA, INSERM, CNRS, Angers University and Nantes University, Nantes, France
16Service d’hématologie clinique du CHU de Nantes, INSERM CRCINA Nantes-Angers, NeXT Université de Nantes, Nantes, France
17Université de Nantes, INSERM UMR 892, CNRS UMR 6299, Nantes, France
18Department of Hematology, University Hospital of Nantes, Nantes, France
19Department of Hematology and Cell Therapy, CHU Nantes, Nantes, France

Archana Ramgopal, DO1, Beth Carella, DO2, Paul Szabolcs, MD3, Steven William Allen, MD, BS4 and Jessie L. Barnum, MD5

1UPMC, Department of Pediatrics, Division of Hematology/Oncology, University of Pittsburgh School of Medicine, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA
2Division of Blood and Marrow Transplantation and Cellular Therapy, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA
3Division of Blood and Marrow Transplantation and Cellular Therapy, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
4UPMC Children's Hospital of Pittsburgh, University Pittsburgh School of Medicine, Pittsburgh, PA
5Children's Hospital of Pittsburgh, Pittsburgh, PA

Yuanyuan Shi1*, Guixin Zhang1*, Yi He1*, Ming-Zhe Han1, Sizhou Feng, MD1*, Rongli Zhang, MD1* and Erlie Jiang2*

1National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Kittika Poonsombudlert, MD1, Jakrin Kewcharoen, MD2*, Chattip Prueksapraopong, MD3* and Limpruttidham Nath, MD, MPH4*

1Holden Comprehensive Cancer Center, University of Iowa Hospital and Clinics, hematology-oncology fellowship program, Iowa city, IA
2University of Hawaii Internal Medicine Residency Program, Honolulu, HI
3Kapi'olani Medical Center for Women & Children, University of Hawaii Pediatric Residency Program, Honolulu, HI
4Queens Medical Center, Queen's Heart department, University of Hawaii Cardiovascular Disease Fellowship Program, Honolulu, HI

Binbin Zheng-Lin, MD MSc1*, Nirupama Krishnamurthi, MD MPH1*, Benjamin Diamond, MD2, Kylee H Maclachlan, MBChB, PhD3*, Francesco Maura, MD3, Ola Landgren, MD, PhD3 and David J. Chung, MD, PhD4

1Department of Medicine, Icahn School of Medicine, Mount Sinai Morning and Mount Sinai West, New York, NY
2Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Sagar S. Patel, MD1, Kwang Woo Ahn, PhD2,3*, Manoj Khanal, BS, MS2*, Caitrin Fretham, MPH4*, Celalettin Ustun, MD5, Betty K. Hamilton, MD6, Navneet S. Majhail, MD, MS6, Shin Mineishi, MD7, Bipin N. Savani, MD8, Mohamed Sorror, MD, MSc9,10*, Edward A. Stadtmauer, MD, FACP11, Brent Logan, PhD2,3*, Marcelo C. Pasquini, MD, MS12,13 and Saurabh Chhabra, MD, MS14,15

1Blood and Marrow Transplant Program, University of Utah Health, Salt Lake City, UT
2Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
3Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI
4National Marrow Donor Program/Be The Match, Minneapolis, MN
5Division of Hematology, Oncology and Cell Therapy, Rush University Medical Center, Chicago, IL
6Department of Hematology and Medical Oncology, Leukemia Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
7Penn State Cancer Institute, Penn State Hershey Medical Center, Hershey, PA
8Department of Medicine, Division of Hematology-Oncology, Vanderbilt University, Brentwood, TN
9Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
10Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA
11University of Pennsylvania Abramson Cancer Center, Philadelphia, PA
12CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
13Froedtert & The Medical College Cancer Ctr., Milwaukee, WI
14Department of Medicine, CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
15Medical College of Wisconsin, Milwaukee, WI

Yang Liang Boo, MD1*, Yeh Ching Linn, MBBS, MRCP2*, Rajat Bhattacharyya3*, Michelle Li Mei Poon, MBBS, MRCP1*, Zi Yi Lim, MB ChB4*, Michaela Su-Fern Seng, MBBS3*, Poh Lin Tan, MBBS5*, Colin Phipps Diong, MB BCh BAO6*, Balamurugan Vellayappan, MBBS7*, Ah Moy Tan, MD3*, Lip Kun Tan, MBBS, FRCP, FRCPath1*, Yvonne Su Ming Loh, MBBS8, Teck Guan Soh1*, Gina Gan2*, Yin Jie Koh1*, Wing Hang Leung, MBBS3* and Liang Piu Koh, MBBS, MRCP1*

1Department of Haematology­-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore
2Department of Hematology, Singapore General Hospital, Singapore, Singapore
3Department of Paediatrics, KK Women’s and Children’s Hospital, Singapore, Singapore
4Center for Clinical Hematology, Mount Elizabeth Novena Medical Center, Singapore, Singapore
5Department of Paediatrics, National University Hospital, Singapore, Singapore
6Parkway Cancer Center, Mount Elizabeth Novena Medical Center, Singapore, Singapore
7Department of Radiation Oncology, National University Cancer Institute, Singapore, Singapore
8Raffles Cancer Center, Raffles Hospital, Singapore, Singapore, Singapore

Christine S Higham*, Alexis Melton, MD, PhD*, Sandhya Kharbanda, MD, Jasmeen Dara, MD*, Lena E. Winestone, MD, MSHP, James N Huang, MD and Kristin A. Shimano, MD

Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, Benioff Children's Hospital, San Francisco, CA

Issa F. Khouri, MD1, Stephen K. Gruschkus, PhD, MPH2*, Alison Gulbis3*, Celina Ledesma1*, Nitin Jain, MD4, Tapan M. Kadia, MD5, Naveen Pemmaraju, MD6, Paolo Anderlini1, Qaiser Bashir, MD7, May Daher7, Partow Kebriaei, MD1, David Marin8, Rohtesh Mehta1*, Uday R. Popat, MD7, Neeraj Saini, MD9, Samer A. Srour, MD, MS7, Jin S. Im7, Luis Fayad10, Ranjit Nair, MD11, Swaminathan P Iyer, MD12, Paolo Strati, MD13, Felipe Samaniego, MD14, Loretta J. Nastoupil, MD10, Christopher Flowers, MD, MS10, Gabriela Rondon8, Hagop M. Kantarjian, MD4, Richard E. Champlin, MD8 and Elias Jabbour, MD6

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX
2Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX
3Pharmacy, The University of Texas M.D. Anderson Cancer Center, Houston, TX
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
6Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
7Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX
10Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX
11Department of Lymphoma/Myeloma, University of Texas M.D. Anderson Cancer Center, Pearland, TX
12Department of Lymphoma and Myeloma, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
13Department of Lymphoma and Myeloma; Department of Translational Molecular Pathology, MD Anderson Cancer Center:, Houston, TX
14Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH